Sandra C. Frommel

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors

Daniel Zingg, Julien Debbache, Simon M. Schaefer et al. · Nature Communications · 2015 · 334 citations · Full text

Medicine, Molecular Biology, Oncology +17

BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence

Lei Gu, Sandra C. Frommel, Christopher C. Oakes et al. · Nature Genetics · 2014 · 151 citations · Full text

Medicine, Molecular Biology, Oncology +16

lncRNA Maturation to Initiate Heterochromatin Formation in the Nucleolus Is Required for Exit from Pluripotency in ESCs

Nataša Savić, Dominik Bär, Sergio Leone et al. · Cell stem cell · 2014 · 149 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +12

DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells

Samia B. Bachmann, Sandra C. Frommel, Rosalba Camicia et al. · Molecular Cancer · 2014 · 109 citations · Full text

Medicine, Molecular Biology, Oncology +11

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

Phil F. Cheng, Olga Shakhova, Daniel Widmer et al. · Genome Biology · 2015 · 100 citations · Full text

Medicine, Cancer Biology, Oncology +17